— Know what they know.
Not Investment Advice

NNRX OTC

Nutranomics, Inc.
1W: +0.0% 1M: +4900.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -50.0% 5Y: -66.7%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 51 · $816232 mcap · 4.19B float · 0.0093% daily turnover

Cash Flow Trends

Operating Cash Flow
-$5M -195.5% ▼
Capital Expenditures
$267K +37.8% ▲
5Y CAGR: +183.3%
Free Cash Flow
-$6M -153.0% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$12K -96.4% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2015FY2019FY2020FY2021FY2022
— Operating Activities —
Net Income-$1M-$2M-$951K-$2M-$5M
Depreciation & Amort.$60K$0$0$259K$115K
Stock-Based Comp.$565K$0$3$0$0
Change in Working Capital$98K$231K$241K-$292K-$1M
Other Non-Cash Items$64K$2M$140K$0$1M
Operating Cash Flow-$431K-$168K-$570K-$2M-$5M
— Investing Activities —
Capital Expenditures$0$0$0-$428K-$267K
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing-$1K$0$0$0$3M
Investing Cash Flow-$1K$0$0-$428K$3M
— Financing Activities —
Net Debt Issuance$406K$168K$20K$429K$957K
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$1K$0$551K$2M$0
Financing Cash Flow$443K$168K$571K$2M$2M
Net Change in Cash$11K$130$604$332K$12K
Cash End of Period$90K$739$1K$333K$345K
Free Cash Flow-$431K-$168K-$570K-$2M-$6M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms